Interested in this fund?
Log in or create an account to request more information.
Gain a deeper and comprehensive understanding of how this fund generates positive impact in the themes and SDGs that matter to you, with insights provided by our dedicated team of expert analysts, and receive notifications about new available impact products, exciting investment opportunities, and relevant updates in the world of impact investing.
Fund geography
Emerging countries (256) / Asia (67) / South-Eastern Asia (21) / Indonesia (2)
Quadria Capital is a US$300m Asia healthcare focused private equity fund that aims to maximize returns by investing in the high growth healthcare sector of some of the world’s fastest growing economies in South Asia and Southeast Asia, including Healthcare Delivery, Life Sciences, Medical Technology and Associated Healthcare Services subsectors. The Fund aims to create significant and sustainable shareholder value by supporting strong, professionally run, stable and scalable healthcare organizations to address the critical and undersupplied healthcare needs in Asia. Quadria Capital seeks to add meaningful value to its portfolio companies via the management team’s healthcare industry know ledge, specialist operating experience, tried and tested value creation strategies and experience in structuring complex transactions.
Further, Quadria Capital believes that its goals of both “doing good” and “doing well” are not just compatible, but in fact, mutually reinforcing. Quadria Capital also believes that responsible investing is critical to sustainable, long term value creation. By working together with investee companies, local communities and government bodies, Quadria Capital seeks to integrate environmental, social and corporate governance impact into its investment decisions, portfolio company management and value creation strategies in order to drive positive developmental impact above and beyond financial returns.
Asset class
Fund status
Fund style
Financial description
The fund seeks to invest primarily in controlling stakes of high quality fast growth healthcare companies in Asia with strong, stable cashflows and experienced management teams. The fund may also invest in sizable minority stakes alongside partners and like minded investors.
12 years
of track record
2012
the year funded
300,000,000 USD
AUM
Interested in this fund?
Log in or create an account to request more information.
Gain a deeper and comprehensive understanding of how this fund generates positive impact in the themes and SDGs that matter to you, with insights provided by our dedicated team of expert analysts, and receive notifications about new available impact products, exciting investment opportunities, and relevant updates in the world of impact investing.
Asset manager
Impact Category
Key performance indicators
Fund overview
Asset manager: Quadria Capital Investment Management
Product track record: Fund has 12 years of track record
Target IRR: 25%
Committed Capital: 0 USD (US Dollar)
Target return category: Risk-adjusted market-rate of return
Fund domicile: Cayman Islands
Product status: Open - post first close
Style/Stage: Buy Out, Growth Stage
Inception year: 2012
Vintage year: 2013
Target region: Asia, Emerging countries, Indonesia, South-Eastern Asia
Target close date: 01/03/2014
Product term: 8 years +2x 1-yr ext
Assets under management: 300,000,000 USD (US Dollar)
Investment size: Min: 10,000,000; Max: 60,000,000; Avg: 35,000,000
Co-investment policy: LPs have priority, With LPs and non-LPs
Currency of investments: USD (US Dollar)
Currency for fund / product figures: USD (US Dollar)
Fund investments to date: 0
Fund investments to date exited or repaid: 0
Management fee: 2%
Carried interest: 20%
Hurdle rate: 8%%
GIIN Investors' Council Investment: Yes
Limited Partners / Investors: Religare Global Asset Management, IMC Investments, Goldis, Medtronic and IFC
Limited Partner / Investor Type: Development Finance Institution (DFI), Endowments/Foundations, Family Office, Pension Funds, Other Institutional Investors
Contact
E-mail: mervin.teo@quadriacapital.com
Website: http://www.quadriacapital.com
Phone number: +65 6221 6779
If you wish to have your details removed from this database please email gdpr@impactyield.com
Abrar Mir
Managing Partner
Mervin Teo
Associate
Impact Performance
n.a.
Impact thesis
As a healthcare private equity investor in Asia, Quadria Capital seeks to make a meaningful, positive impact by increasing access to affordable, high quality healthcare to underserved populations that need it the most. Quadria Capital is focused on leveraging its healthcare expertise to enable greater efficiency to healthcare provision, improve health outcomes and increase access to affordable, high quality healthcare for underserved patient populations. With Asia significantly trailing its developed counterparts in healthcare spending, increased catch-up spending via private equity capital will also assist in the overall economic development of the region.
By working together with investee companies, local communities and government bodies, Quadria Capital seeks to integrate environmental, social and corporate governance impact into its investment decisions, portfolio company management and value creation strategies in order to drive positive developmental impact above and beyond financial returns.
Quadria Capital adheres to the Global Impact Investing Rating System and United Nation’s Principles for Responsible Investment. Quadria Capital has also worked closely with the International Finance Corporation (IFC) and has adopted IFC’s policies and procedures for social and environmental considerations for private equity funds.
Impact Management
n.a.